Search

everythinglearnresearchcommunity

for

Search:↓

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Blocking interferon-gamma might help treat various autoimmune diseases.

Sun-exposed skin shows different cell activity and gene expression, suggesting targets to prevent skin aging and cancer.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Anti-TNF therapy can cause weight gain and hair loss, leading some patients to stop treatment.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

Fenugreek extract may help treat benign prostatic hyperplasia.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Some drugs used to treat immune conditions may cause different types of hair loss.